{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:17:36Z","timestamp":1788545856018,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO.81773016"],"award-info":[{"award-number":["NO.81773016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO.31471297"],"award-info":[{"award-number":["NO.31471297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["NO.LY18C060001"],"award-info":[{"award-number":["NO.LY18C060001"]}]},{"name":"Fundamental Research Funds for the Central Universities","award":["NO.419600*172210176"],"award-info":[{"award-number":["NO.419600*172210176"]}]},{"name":"WeiJian Special Foundation, Zhejiang University"},{"name":"School of Public Health","award":["2016C33150"],"award-info":[{"award-number":["2016C33150"]}]},{"DOI":"10.13039\/501100010218","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.taap.2018.12.019","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T03:13:10Z","timestamp":1545880390000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination"],"prefix":"10.1016","volume":"365","author":[{"given":"Hanwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9892-9584","authenticated-orcid":false,"given":"Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuequn","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhang","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4871-8789","authenticated-orcid":false,"given":"Yihua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.12.019_bb0005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2014.5994","article-title":"Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?","volume":"22","author":"Abais","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.taap.2018.12.019_bb0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2018.12.019_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-3083.2003.01213.x","article-title":"Effect of flavone derivatives on interleukin-1beta (IL-1beta) mRNA expression and IL-1beta protein synthesis in stimulated RAW 264.7 macrophages","volume":"57","author":"Blonska","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.taap.2018.12.019_bb0020","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.20100257","article-title":"Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella","volume":"207","author":"Broz","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2018.12.019_bb0025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2014.01.063","article-title":"Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation","volume":"156","author":"Cai","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.taap.2018.12.019_bb0030","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.febslet.2011.03.046","article-title":"Inhibition and disaggregation of alpha-synuclein oligomers by natural polyphenolic compounds","volume":"585","author":"Caruana","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2018.12.019_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.intimp.2016.08.038","article-title":"Anti-oxidative assays as markers for anti-inflammatory activity of flavonoids","volume":"40","author":"Chanput","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2018.12.019_bb0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2018.12.019_bb0045","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.1301676","article-title":"Apoptosis-associated speck-like protein containing a CARD forms specks but does not activate caspase-1 in the absence of NLRP3 during macrophage swelling","volume":"194","author":"Compan","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2018.12.019_bb0050","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","article-title":"The inflammasome NLRs in immunity, inflammation, and associated diseases","volume":"29","author":"Davis","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.taap.2018.12.019_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lfs.2015.10.004","article-title":"Molecular mechanisms underlying anticancer effects of myricetin","volume":"142","author":"Devi","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2018.12.019_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11929","article-title":"ASC filament formation serves as a signal amplification mechanism for inflammasomes","volume":"7","author":"Dick","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2018.12.019_bb0065","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.taap.2018.12.019_bb0070","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.taap.2018.12.019_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131758","article-title":"Dual action of Myricetin on Porphyromonas gingivalis and the inflammatory response of host cells: a promising therapeutic molecule for periodontal diseases","volume":"10","author":"Grenier","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2018.12.019_bb0080","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2018.12.019_bb0085","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.taap.2018.12.019_bb0090","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.taap.2018.12.019_bb0095","doi-asserted-by":"crossref","first-page":"18124","DOI":"10.1074\/jbc.M115.645549","article-title":"Lipopolysaccharide primes the NALP3 inflammasome by inhibiting its ubiquitination and degradation mediated by the SCFFBXL2 E3 ligase","volume":"290","author":"Han","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.12.019_bb0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.taap.2018.12.019_bb0105","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.4155\/fmc-2018-0172","article-title":"Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models","volume":"10","author":"Hou","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.taap.2018.12.019_bb0110","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.molcel.2007.11.019","article-title":"The age of crosstalk: phosphorylation, ubiquitination, and beyond","volume":"28","author":"Hunter","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2018.12.019_bb0115","doi-asserted-by":"crossref","first-page":"36617","DOI":"10.1074\/jbc.M112.407130","article-title":"Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation","volume":"287","author":"Juliana","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.12.019_bb0120","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.3390\/ijms11114348","article-title":"Myricetin protects cells against oxidative stress-induced apoptosis via regulation of PI3K\/Akt and MAPK signaling pathways","volume":"11","author":"Kang","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2018.12.019_bb0125","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.lfs.2005.05.026","article-title":"Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-alpha- and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63","volume":"77","author":"Kuo","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2018.12.019_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.taap.2018.12.019_bb0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2016.05.025","article-title":"Flavonoid myricetin inhibits TNF-alpha-stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF-kappaB pathways in human keratinocytes","volume":"784","author":"Lee da","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2018.12.019_bb0140","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bbalip.2008.06.009","article-title":"Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages","volume":"1781","author":"Lian","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"8370593","key":"10.1016\/j.taap.2018.12.019_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/8370593","article-title":"Myricetin possesses potential protective effects on diabetic cardiomyopathy through Inhibiting IkappaBalpha\/NFkappaB and enhancing Nrf2\/HO-1","volume":"2017","author":"Liao","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.taap.2018.12.019_bb0150","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1074\/jbc.M112.422238","article-title":"Deubiquitinases regulate the activity of caspase-1 and interleukin-1beta secretion via assembly of the inflammasome","volume":"288","author":"Lopez-Castejon","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.12.019_bb0155","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1158\/0008-5472.CAN-05-3310","article-title":"Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity","volume":"66","author":"Lu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2018.12.019_bb0160","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.taap.2018.12.019_bb0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.taap.2018.12.019_bb0170","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0006-2952(97)00648-5","article-title":"Involvement of phenoxyl radical intermediates in lipid antioxidant action of myricetin in iron-treated rat hepatocyte culture","volume":"55","author":"Morel","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2018.12.019_bb0175","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0006-2952(95)02195-7","article-title":"Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation","volume":"51","author":"Ong","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2018.12.019_bb0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","article-title":"Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro","volume":"97","author":"Ono","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2018.12.019_bb0185","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1471-4159.2003.01976.x","article-title":"Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease","volume":"87","author":"Ono","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2018.12.019_bb0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2018.12.019_bb0195","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.20132486","article-title":"The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation","volume":"211","author":"Rodgers","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2018.12.019_bb0200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.febslet.2008.12.037","article-title":"Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia\/reperfusion-induced injury","volume":"583","author":"Scarabelli","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2018.12.019_bb0205","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.taap.2018.12.019_bb0210","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/nu8020090","article-title":"Myricetin: a dietary molecule with diverse biological activities","volume":"8","author":"Semwal","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.taap.2018.12.019_bb0215","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2009.04.002","article-title":"Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2","volume":"283","author":"Siegelin","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2018.12.019_bb0220","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","article-title":"Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine","volume":"6","author":"Walker","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2018.12.019_bb0225","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.taap.2018.12.019_bb0230","doi-asserted-by":"crossref","first-page":"10177","DOI":"10.1021\/jm301273u","article-title":"Order and disorder: differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target","volume":"55","author":"Williams","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2018.12.019_bb0235","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1873-3468.12782","article-title":"A rapid administration of GW4064 inhibits the NLRP3 inflammasome activation independent of farnesoid X receptor agonism","volume":"591","author":"Xie","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2018.12.019_bb0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.taap.2018.12.019_bb0245","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1016\/j.ejmech.2011.07.031","article-title":"Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro","volume":"46","author":"Zhang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2018.12.019_bb0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18305787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18305787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:43:20Z","timestamp":1565228600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18305787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":50,"alternative-id":["S0041008X18305787"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.12.019","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}